Erudio Healtherudio.com
Drug
ELI-002 7P trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying ELI-002 7P: AMPLIFY-7P. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| AMPLIFY-7P NCT05726864 · Elicio Therapeutics | KRAS/NRAS-mutated solid tumors | Phase 1/Phase 2 | 294 | 91 | Standard | Nov 13, 2026 | Preview |